Lung Transplant for Interstitial Lung Diseases

B. Nokes, E. Golts, K. Afshar
{"title":"Lung Transplant for Interstitial Lung Diseases","authors":"B. Nokes, E. Golts, K. Afshar","doi":"10.5772/INTECHOPEN.82722","DOIUrl":null,"url":null,"abstract":"Lung transplant is an important treatment modality for select cases of advanced interstitial lung disease. However, the preand postoperative management requires several unique considerations. The decision to transplant is based largely on clinical severity of illness and the lung allocation score. Transplant improves overall mortality across the interstitial lung diseases, though not all ILD subtypes experience equal benefit from lung transplant. Broadly speaking, there is no difference in benefit between singleand bilateral-lung transplants, though we will discuss some important clinical nuances to this decision as well. Lastly, there are a number of immunosuppression, coagulation, and malignancy risk considerations that must be carefully understood in caring for the lung transplant patient. This chapter will provide a general overview of the indications for lung transplant, risk stratification for lung transplant across the interstitial lung diseases, as well as general postoperative management details.","PeriodicalId":425067,"journal":{"name":"Interstitial Lung Diseases","volume":"18 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interstitial Lung Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/INTECHOPEN.82722","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Lung transplant is an important treatment modality for select cases of advanced interstitial lung disease. However, the preand postoperative management requires several unique considerations. The decision to transplant is based largely on clinical severity of illness and the lung allocation score. Transplant improves overall mortality across the interstitial lung diseases, though not all ILD subtypes experience equal benefit from lung transplant. Broadly speaking, there is no difference in benefit between singleand bilateral-lung transplants, though we will discuss some important clinical nuances to this decision as well. Lastly, there are a number of immunosuppression, coagulation, and malignancy risk considerations that must be carefully understood in caring for the lung transplant patient. This chapter will provide a general overview of the indications for lung transplant, risk stratification for lung transplant across the interstitial lung diseases, as well as general postoperative management details.
肺移植治疗间质性肺疾病
肺移植是晚期间质性肺疾病的重要治疗方式。然而,术前和术后处理需要几个独特的考虑因素。移植的决定主要基于疾病的临床严重程度和肺分配评分。移植可改善间质性肺疾病的总体死亡率,但并非所有ILD亚型均可从肺移植中获益。一般来说,单肺移植和双肺移植的益处没有区别,尽管我们也会讨论一些重要的临床差异。最后,在照顾肺移植患者时,必须仔细了解一些免疫抑制、凝血和恶性肿瘤风险因素。本章将概述肺移植的适应症,跨间质性肺疾病肺移植的风险分层,以及一般的术后处理细节。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信